Compare IPHA & ESP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IPHA | ESP |
|---|---|---|
| Founded | 1999 | 1928 |
| Country | France | United States |
| Employees | 163 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.5M | 165.6M |
| IPO Year | N/A | 1995 |
| Metric | IPHA | ESP |
|---|---|---|
| Price | $1.75 | $61.75 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $5.75 | ★ $64.00 |
| AVG Volume (30 Days) | 16.4K | ★ 17.5K |
| Earning Date | 03-26-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 1.50% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.74 |
| Revenue | N/A | ★ $43,950,872.00 |
| Revenue This Year | $180.36 | $10.30 |
| Revenue Next Year | N/A | $10.00 |
| P/E Ratio | ★ N/A | $22.25 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.18 | $36.00 |
| 52 Week High | $2.63 | $74.77 |
| Indicator | IPHA | ESP |
|---|---|---|
| Relative Strength Index (RSI) | 53.70 | 52.79 |
| Support Level | $1.73 | $53.68 |
| Resistance Level | $1.90 | $61.58 |
| Average True Range (ATR) | 0.07 | 2.36 |
| MACD | -0.01 | 0.68 |
| Stochastic Oscillator | 55.59 | 83.27 |
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through its ANKET platform, and antibody-drug conjugates (ADC). Its portfolio includes lacutamab, which is being studied for cutaneous T-cell lymphomas and peripheral T-cell lymphomas, and monalizumab, which is being developed in collaboration with AstraZeneca for non-small cell lung cancer. The company's revenue mainly consists of revenues from collaboration and licensing agreements and government financing for research expenditure in the form of research tax credits, as well as other grants.
Espey Manufacturing & Electronics Corp is a power electronics design and OEM manufacturing company delivering products for military and severe environment applications. Its products include power supplies, power converters, filters, power transformers, magnetic components, power distribution equipment, UPS systems, and antennas. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power. Espey services include design and development to specification, build to specifications provided by the customer, build to print, design services, design studies, environmental testing services, metal fabrication, painting services, and development of automatic testing equipment.